Read more about Niraparib Significantly Improves Outcome of Ovarian Cancer Patients
Oct 11, 2016
Niraparib Significantly Improves Outcome of Ovarian Cancer Patients
...and without germline BRCA mutations. In a randomized, double-blind, phase III trial of over 550 women both with and without germline BRCA mutations, researchers found that patients receiving niraparib once...